Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

• Main Authors: Amanda Jane Leach (Author), Edward Kim Mulholland (Author), Mathuram Santosham (Author), Paul John Torzillo (Author), Peter McIntyre (Author), Heidi Smith-Vaughan (Author), Nicole Wilson (Author), Beth Arrowsmith (Author), Jemima Beissbarth (Author), Mark D. Chatfield (Author), Victor M. Oguoma (Author), Peter Stanley Morris (Author)
• Format: Book
• Published: BMC, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Aboriginal children living in Australian remote communities are at high risk of early and persistent otitis media, hearing loss, and social disadvantage. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are the primary pathogens. We compared otitis media ou...